CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months

被引：2
|
作者：
Yao, Zhenzhen [1 ]
Gu, Bin [1 ]
Chen, Jia [1 ,2 ]
Xu, Yang [1 ,2 ,3 ]
Chen, Feng [1 ]
Xue, Shengli [1 ,2 ]
Qiu, Huiying [1 ,2 ]
Tang, Xiaowen [1 ,2 ,3 ]
Han, Yue [1 ,2 ,3 ]
Chen, Suning [1 ,2 ,3 ]
Sun, Aining [1 ,2 ]
Yu, Lei [4 ]
Zhang, Yanming [5 ]
Wu, Depei [1 ,2 ,3 ,6 ]
Wang, Ying [1 ,2 ,3 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Suzhou, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Minist Hlth, Key Lab Thrombosis & Hemostasis, Suzhou, Peoples R China
[4] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
[5] Xuzhou Med Univ, Huaian Hosp, Peoples Hosp Huaian 2, Dept Hematol, Huaian, Peoples R China
[6] Soochow Univ, State Key Lab Radiat Med & Protect, Suzhou, Peoples R China
来源：
BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期
基金：
中国国家自然科学基金;
关键词：
REMISSION; CHILDREN; IMPACT;
D O I：
10.1038/s41408-023-00848-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy
    Tambaro, Francesco Paolo
    Khazal, Sajad
    Nunez, Cesar
    Ragoonanan, Dristhi
    Tewari, Priti
    Petropoulos, Demetrios
    Kebriaei, Partow
    Wierda, William George
    Mahadeo, Kris Michael
    CLINICAL CASE REPORTS, 2020, 8 (09): : 1678 - 1681
  • [22] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Aiyun Jin
    Jingjing Feng
    Guoqing Wei
    Wenjun Wu
    Luxin Yang
    Huijun Xu
    Yanlei Zhang
    Jiazhen Cui
    Alex Hongsheng Chang
    Yongxian Hu
    He Huang
    Bone Marrow Transplantation, 2020, 55 : 717 - 721
  • [23] Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell therapies do not prevent disease from relapsing in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Tang, Yu
    Fei, Xiaoming
    Yu, Xianqiu
    Cao, Jiang
    Wang, Lixia
    Lei, Fang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
    Jin, Aiyun
    Feng, Jingjing
    Wei, Guoqing
    Wu, Wenjun
    Yang, Luxin
    Xu, Huijun
    Zhang, Yanlei
    Cui, Jiazhen
    Chang, Alex Hongsheng
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2020, 55 (04) : 717 - 721
  • [25] Outcome of Patients (Pts) with Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) without 3-Month Complete Molecular Response (CMR)
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Short, Nicholas J.
    Khouri, Rita
    Khoury, Joseph D.
    Champlin, Richard E.
    Kebriaei, Partow
    Cortes, Jorge E.
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    Borthakur, Gautam M.
    Verstovsek, Srdan
    Daver, Naval G.
    Montalban-Bravo, Guillermo
    Jain, Nitin
    Konopleva, Marina Y.
    Yilmaz, Musa E.
    Naqvi, Kiran
    O'Brien, Susan M.
    Ravandi, Farhad
    Jabbour, Elias
    BLOOD, 2019, 134
  • [26] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Yiyun Wang
    Yingying Yang
    Ruimin Hong
    Houli Zhao
    Guoqing Wei
    Wenjun Wu
    Huijun Xu
    Jiazhen Cui
    Yanlei Zhang
    Alex H. Chang
    Yongxian Hu
    He Huang
    Blood Cancer Journal, 10
  • [27] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Wang, Yiyun
    Yang, Yingying
    Hong, Ruimin
    Zhao, Houli
    Wei, Guoqing
    Wu, Wenjun
    Xu, Huijun
    Cui, Jiazhen
    Zhang, Yanlei
    Chang, Alex H.
    Hu, Yongxian
    Huang, He
    BLOOD CANCER JOURNAL, 2020, 10 (10)
  • [28] CD19 Directed Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
    Anagnostou, Theodora
    Bin Riaz, Irbaz
    Hashmi, Shahrukh K.
    Murad, Mohammad Hassan
    Kenderian, Saad S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [29] Cluster of differentiation 19 chimeric antigen receptor T-cell therapy in pediatric acute lymphoblastic leukemia
    Fu, Zexin
    Zhou, Jinlei
    Chen, Rui
    Jin, Yihua
    Ni, Ting
    Qian, Lingbo
    Xiao, Chi
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [30] A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia
    Hu, Yongxian
    Wang, Jiasheng
    Wei, Guoqing
    Yu, Jian
    Luo, Yi
    Shi, Jimin
    Wu, Wenjun
    Zhao, Kui
    Xiao, Lei
    Zhang, Yanlei
    Wu, Zhao
    Xu, Huijun
    Chang, Alex Hongsheng
    Huang, He
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1208 - 1217
12345